SYNNOVA HEALTH, INC. – Trademark Portfolio
Entity Type: 03
SYNNOVA HEALTH, INC. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 45 (Legal & Security Services) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SYNNOVA HEALTH. The owner is based in PALMETTO BAY, FL.
18001 OLD CUTLER ROAD
SUITE 429
PALMETTO BAY, FL 33157
Showing of trademarks Trademarks
Trademark Classifications
SYNNOVA HEALTH, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Legal services; security services for the protection of property and individuals
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does SYNNOVA HEALTH, INC. have?
SYNNOVA HEALTH, INC. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 1 cancelled.
What trademark classes does SYNNOVA HEALTH, INC. file in?
SYNNOVA HEALTH, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are SYNNOVA HEALTH, INC.'s most well-known trademarks?
SYNNOVA HEALTH, INC.'s registered trademark portfolio includes well-known marks such as SYNNOVA HEALTH. These are among 1 currently registered trademark in the portfolio.
What is SYNNOVA HEALTH, INC.'s trademark registration success rate?
SYNNOVA HEALTH, INC. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.